Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Biocon Limited
Biocon Limited
Duke University
M.D. Anderson Cancer Center
West Virginia University
McMaster University
AccSalus Biosciences, Inc.
Petrov, Andrey
Kyowa Kirin Co., Ltd.
Hangzhou DAC Biotechnology Co., Ltd.
Vastra Gotaland Region
Biotroy Therapeutics
Ankyra Therapeutics, Inc
Boston Immune Technologies and Therapeutics
Peking University Cancer Hospital & Institute
Vastra Gotaland Region